ProCE Banner Activity

Understanding and Communicating Safety Evidence With CAR T-Cell Therapy in Lymphomas

Slideset

Download these slides for an overview of toxicity, including prophylaxis and management strategies, with CAR T-cell therapy.

Released: September 06, 2024

Expiration: September 05, 2025

Share

Faculty

Beth Faiman

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, Ohio

Christopher J D'Andrea

Christopher J D'Andrea, PA-C

Hematology and Medical Oncology
Taussig Cancer Center
Cleveland Clinic
Cleveland, Ohio

Provided by

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Bristol Myers Squibb and Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Bristol Myers Squibb

Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner